Skip to main content

Together we are beating cancer

Donate now

ASCO conference

Showing 12 out of 32 results
ASCO 2015
  • Science & Technology
  • Health & Medicine

ASCO 2015 round-up: immunotherapy continues to come of age

We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference. We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference.

by Alan Worsley | Analysis | 5 June 2015

5 June 2015

vitamin pills

This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story

by Henry Scowcroft | Analysis | 15 May 2015

15 May 2015

A handshake
  • Science & Technology
  • Health & Medicine

New immunotherapy drugs hit the headlines - how do they work?

In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers. In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.

by Henry Scowcroft | Analysis | 2 June 2014

2 June 2014